Drugs / TH9619
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07151040 | Aug 2025 → Dec 2026 expected | colorectal cancer, gastric cancer, gastroesophageal cancer, head and neck squamous cell carcinoma +1 | One-carbon Therapeutics AB | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TH9619 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07151040 ↗ |